Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Increased expression of ACE2, the SARS-CoV-2 entry receptor, in alveolar and bronchial epithelium of smokers and COPD subjects
Merel Jacobs, Hannelore P. Van Eeckhoutte, Sara Wijnant, et al.
European Respiratory Journal (2020) Vol. 56, Iss. 2, pp. 2002378-2002378
Open Access | Times Cited: 85

Showing 26-50 of 85 citing articles:

Deregulation of interferon-gamma receptor 1 expression and its implications for lung adenocarcinoma progression
Ángeles C. Tecalco-Cruz, Karen H Medina-Abreu, Enrique Oropeza-Martínez, et al.
World Journal of Clinical Oncology (2024) Vol. 15, Iss. 2, pp. 195-207
Open Access | Times Cited: 4
Distinguishing non severe cases of dengue from COVID-19 in the context of co-epidemics: A cohort study in a SARS-CoV-2 testing center on Reunion island
Antoine Joubert, F. Andry, A. Bertolotti, et al.
PLoS neglected tropical diseases (2021) Vol. 15, Iss. 4, pp. e0008879-e0008879
Open Access | Times Cited: 25
Lung function impairment in relation to cognition and vascular brain lesions: the Rotterdam Study
Tian Xiao, Sara Wijnant, Isabelle van der Velpen, et al.
Journal of Neurology (2022) Vol. 269, Iss. 8, pp. 4141-4153
Closed Access | Times Cited: 17
Expression of SARS-CoV-2 entry receptor ACE2 in human brain and its association with Alzheimer’s disease and COVID-19
Sijie Li, Jingyi Sun, He Li, et al.
Molecular Psychiatry (2025)
Closed Access
Angiotensin-converting enzyme 2 expression in COPD and IPF fibroblasts: the forgotten cell in COVID-19
Noof Aloufi, Hussein Traboulsi, Jun Ding, et al.
AJP Lung Cellular and Molecular Physiology (2020) Vol. 320, Iss. 1, pp. L152-L157
Open Access | Times Cited: 27
COVID-19 Disease Course in Former Smokers, Smokers and COPD Patients
Ricardo Wesley Alberca, Júlia Cataldo Lima, Emily Araujo de Oliveira, et al.
Frontiers in Physiology (2021) Vol. 11
Open Access | Times Cited: 21
Association Between ACE2 and Lung Diseases
Cheng Su, Li Cai, Xinyi Hu, et al.
Infection and Drug Resistance (2024) Vol. Volume 17, pp. 1771-1780
Open Access | Times Cited: 3
Effect of ACE1 polymorphism rs1799752 on protein levels of ACE2, the SARS-CoV-2 entry receptor, in alveolar lung epithelium
Merel Jacobs, Lies Lahousse, Hannelore P. Van Eeckhoutte, et al.
ERJ Open Research (2021) Vol. 7, Iss. 2, pp. 00940-2020
Open Access | Times Cited: 19
SARS-CoV-2 (COVID-19) Adhesion Site Protein Upregulation in Small Airways, Type 2 Pneumocytes, and Alveolar Macrophages of Smokers and COPD – Possible Implications for Interstitial Fibrosis
Samuel James Brake, Mathew Suji Eapen, Kielan Darcy McAlinden, et al.
International Journal of COPD (2022) Vol. Volume 17, pp. 101-115
Open Access | Times Cited: 14
Clinical features and efficacy of antiviral drug, Arbidol in 220 nonemergency COVID‐19 patients from East-West-Lake Shelter Hospital in Wuhan: a retrospective case series
Wei Gao, Si Chen, Kun Wang, et al.
Virology Journal (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 20
Dysbalance ofACE2levels – a possible cause for severeCOVID‐19 outcome inCOPD
Elisabeth Fließer, Anna Birnhuber, Leigh M. Marsh, et al.
The Journal of Pathology Clinical Research (2021) Vol. 7, Iss. 5, pp. 446-458
Open Access | Times Cited: 18
ACE2, the Counter-Regulatory Renin–Angiotensin System Axis and COVID-19 Severity
Filippos Triposkiadis, Αndrew Xanthopoulos, Grigorios Giamouzis, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 17, pp. 3885-3885
Open Access | Times Cited: 17
Clinical characteristics and predictors for in-hospital mortality in adult COVID-19 patients: A retrospective single center cohort study in Vilnius, Lithuania
Ieva Kubiliute, Monika Vitkauskaitė, Jurgita Urbonienė, et al.
PLoS ONE (2023) Vol. 18, Iss. 8, pp. e0290656-e0290656
Open Access | Times Cited: 7
Current developments and future directions in COPD
Alexander G. Mathioudakis, Lowie E.G.W. Vanfleteren, Lies Lahousse, et al.
European Respiratory Review (2020) Vol. 29, Iss. 158, pp. 200289-200289
Open Access | Times Cited: 18
Differences in Mortality Among Patients With Asthma and COPD Hospitalized With COVID-19
Yunqing Liu, Haseena Rajeevan, Michael Simonov, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 11, pp. 3383-3390.e3
Closed Access | Times Cited: 6
Chronic obstructive pulmonary disease, asthma, and mechanical ventilation are risk factors for dyspnea in patients with long COVID: A Japanese nationwide cohort study
Emiko Matsuyama, Jun Miyata, Hideki Terai, et al.
Respiratory Investigation (2024) Vol. 62, Iss. 6, pp. 1094-1101
Open Access | Times Cited: 2
Paradoxical effects of cigarette smoke and COPD on SARS-CoV-2 infection and disease
Michael Tomchaney, Marco Contoli, Jonathan J. Mayo, et al.
BMC Pulmonary Medicine (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 14
Clinical Characteristics and Survival Analysis in Frequent Alcohol Consumers With COVID-19
Ricardo Wesley Alberca, Paula Ordonhez Rigato, Yasmim Álefe Leuzzi Ramos, et al.
Frontiers in Nutrition (2021) Vol. 8
Open Access | Times Cited: 13
Hypercapnia increases ACE2 expression and pseudo-SARS-CoV-2 entry in bronchial epithelial cells by augmenting cellular cholesterol
Fei Chen, Aiko Matsuda, G. R. Scott Budinger, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Tobacco and COVID-19: Understanding the science and policy implications
Luke Clancy, Silvano Gallus, Janice M. Leung, et al.
Tobacco Induced Diseases (2020) Vol. 18, Iss. December, pp. 1-4
Open Access | Times Cited: 13
Susceptibility of Patients with Airway Disease to SARS-CoV-2 Infection
Francesca Conway, Chloë I. Bloom, Pallav L. Shah
American Journal of Respiratory and Critical Care Medicine (2022) Vol. 206, Iss. 6, pp. 696-703
Open Access | Times Cited: 9
SARS-CoV-2 infection aggravates cigarette smoke-exposed cell damage in primary human airway epithelia
Rui Chen, Kenrie P. Y. Hui, Yingmin Liang, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 5
Does autonomous macrophage-driven inflammation promote alveolar damage in COVID-19?
David H. Dockrell, Clark D Russell, Brian J. McHugh, et al.
European Respiratory Journal (2022) Vol. 60, Iss. 6, pp. 2201521-2201521
Open Access | Times Cited: 8
Knowledge of SARS-CoV-2 Epitopes and Population HLA Types Is Important in the Design of COVID-19 Vaccines
Rafidah Lani, Nurul Aqidah Senin, Sazaly AbuBakar, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1606-1606
Open Access | Times Cited: 8
Paradoxical effects of cigarette smoke and COPD on SARS-CoV2 infection and disease
Michael Tomchaney, Marco Contoli, Jonathan J. Mayo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 11

Scroll to top